Dual antiplatelet therapy (DAPT) is administered following a percutaneous coronary intervention with stenting to reduce the risk of thrombosis and prevent failure of the procedure. The new generation of stents and devices is associated with lesser or no risks of failure and thrombosis. In addition, these devices, like the paclitaxel-coated devices, show promising outcomes and require a shorter duration of DAPT following stenting. To know more about these new generation devices and DAPT, join our exclusive session with a reputed Interventional Cardiologist, Dr.
Kavita Tyagi , on 8 th January 2024 , 6:00 PM IST onwards . Stay Tuned! Suggested readings Microplastics in the Heart – A New Cardiovascular Concern? USFDA Approves Sotagliflozin for Heart Failure-related Complications Heart Stent as an Alternative to Chest Pain Medication for Angina Patients ##Disclaimer## The content provided…
